About Baptist Health South Florida
Baptist Health South Florida is the largest healthcare organization in the region, with 12 hospitals, more than 27,000 employees, 4,000 physicians and 200 outpatient centers, urgent care facilities and physician practices spanning across Miami-Dade, Monroe, Broward and Palm Beach counties. Baptist Health has internationally renowned institutes specializing in cancer care, brain and spine care, heart and vascular care and orthopedic care. In addition, it includes Baptist Health Medical Group; Baptist Health Quality Network; and The Baptist Health PineApp, a virtual health platform. A not-for-profit organization supported by philanthropy and committed to its faith-based charitable mission of medical excellence, Baptist Health has been recognized by Fortune as one of the 100 Best Companies to Work For in America and is the most awarded healthcare system in South Florida by U.S. News and World Report. For more information, visit BaptistHealth.net/Newsroom and connect with us on Facebook, X (formerly Twitter), Instagram, TikTok and LinkedIn.
Connect with us:
October 22, 2024
Article
Samuel A. Kareff, MD, MPH, shares his reflections on the benefits, challenges, and critical elements of effective mentorship in hematology/oncology.
October 21, 2024
Podcast
Dr Kareff discusses the intersections between early-phase clinical research and meaningful mentorship experiences during oncology/hematology fellowship.
August 19, 2024
Article
Noah Kalman, MD, MBA, details new technology for treating head and neck cancer, and ongoing trials examining therapies at Miami Cancer Institute.
June 10, 2024
Video
Rohan Garje, MD, discusses the impact of human papillomavirus status on survival outcomes in penile squamous cell carcinoma.
June 10, 2024
Video
Manmeet Ahluwalia, MD, MBA, FASCO, discusses findings from a National Cancer Database analysis on treatment outcomes of brain metastases from primary RCC.
May 23, 2024
Article
Petros Grivas, MD, PhD, expands on key updates in the second-line management of urothelial cancer.
May 15, 2024
Video
Rohan Garje, MD, discusses emerging biomarkers in metastatic castration-resistant prostate cancer and where the treatment field is headed.
May 14, 2024
Video
Rohan Garje, MD, discusses the utility of lutetium Lu 177 vipivotide tetraxetan in metastatic castration-resistant prostate cancer.
May 08, 2024
Video
Guenther Koehne, MD, PhD, discusses the use of chemotherapy-only conditioning regimens for patients with hematologic malignancies undergoing transplant.
May 04, 2024
Video
Rohan Garje, MD, discusses considerations when choosing between FDA-approved PARP inhibitor–based combinations for patients with mCRPC.
April 30, 2024
Video
John Paul Diaz, MD, discusses the evolving use of precision medicine approaches in cervical cancer management.
April 26, 2024
Article
Rohan Garje, MD, highlights advances made in precision medicine approaches for the management of metastatic prostate cancer.
April 23, 2024
Video
Rohan Garje, MD, discusses the evolving use of genomic testing and targeted treatment approaches in prostate cancer.
April 11, 2024
Podcast
Drs Graff, Mahtani, McCann, and Rugo share moments that sparked their interest in oncology and setbacks they overcame when building their careers.
April 01, 2024
Video
Reshma L. Mahtani, DO, discusses how attempts to address unmet needs in breast cancer have evolved over time.
March 28, 2024
Video
Minesh Mehta, MD, discusses recent advancements in radiation oncology approaches for patients with prostate cancer.
March 27, 2024
Video
Guenther Koehne, MD, PhD, discusses research efforts to overcome resistance to CAR T-cell therapy in hematologic malignancies.
March 27, 2024
Video
Alessandro Villa, DDS, PhD, MPH, discusses the incidence of oral toxicities in patients with head and neck cancer.
March 26, 2024
Video
Minesh Mehta, MD, discusses how MRI-guided adaptive radiation therapy systems may improve disease outcomes in cancer care.
March 22, 2024
Video
Reshma L. Mahtani, DO, discusses how the expansion of HER2-targeted agents has impacted the management of HER2-positive breast cancer.